The ups and downs of transcription factors in melanoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed.

1. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells.The Journal of investigative dermatology · 2018
   Article
2. Uncover disease genes by maximizing information flow in the phenome-interactome network.Bioinformatics (Oxford, England) · 2011
   Article

Corrections and comments

• Commented on by
  GLI2-mediated melanoma invasion and metastasis.2010
• Comment on
  GLI2-mediated melanoma invasion and metastasis.2010
• Comment on
  KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.2010

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as